✦ LIBER ✦

Vascular remodeling and clinical resistance to antiangiogenic cancer therapy

✍ Scribed by Julia Glade Bender; Erin M. Cooney; Jessica J. Kandel; Darrell J. Yamashiro

Book ID: 116413196
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 226 KB
Volume: 7
Category: Article
ISSN: 1368-7646
DOI: 10.1016/j.drup.2004.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers of response and resistance to

Biomarkers of response and resistance to antiangiogenic therapy

✍ Jain, Rakesh K.; Duda, Dan G.; Willett, Christopher G.; Sahani, Dushyant V.; Zhu 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 531 KB

1 Integrin: Critical Path to Antiangioge

1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond

✍ Jahangiri, A.; Aghi, M. K.; Carbonell, W. S. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 339 KB

231 Efficacy of VEGFR2 targeted mAb ther

231 Efficacy of VEGFR2 targeted mAb therapy in preclinical cancer models resistant to antiangiogenic therapy

✍ D. Surguladze; M.J. Plym; J. Malaby; M. Prewett; M. Rutstein; J. Schwartz; D. Lu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Colorectal cancer and antiangiogenic the

Colorectal cancer and antiangiogenic therapy: What can be expected in clinical practice?

✍ Andrea Mancuso; Cora N. Sternberg 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Antiangiogenic drugs: Current knowledge

Antiangiogenic drugs: Current knowledge and new approaches to cancer therapy

✍ Jose L. Mauriz; Javier González-Gallego 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

MP35-14 THE CONTRIBUTION OF METABOLIC RE

MP35-14 THE CONTRIBUTION OF METABOLIC REMODELING TO THERAPY RESISTANCE IN RENAL CANCER

✍ Sudarshan, Sunil; Gayheart, Dustin; Hughes, Tanner; Kapadia, Akash; Benson, Dan 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 381 KB